Skip to main navigation
Skip to main content
Skip to page footer
Home
About
Submenu for "About"
+
What is TA?
+
About EPTA
+
Organisational rules
+
Documentation
+
TA Portal
+
Contact / Current Presidency
Members
Submenu for "Members"
+
Full Members
+
Austria
+
Catalonia
+
European Parliament
+
Finland
+
France
+
Germany
+
Greece
+
Luxembourg
+
Netherlands
+
Norway
+
Spain
+
Sweden
+
Switzerland
+
United Kingdom
+
Associate Members
+
Chile
+
Council of Europe
+
Denmark
+
Japan
+
Korea
+
Lithuania
+
Poland
+
Portugal
+
USA
+
Wallonia
Database
Submenu for "Database"
+
Projects
+
Policy Briefs & Reports
News
Submenu for "News"
+
EPTA News
+
EPTA News Archive
+
News from Members
Internal
You are here:
EPTA
Database
Policy Briefs & Reports
Implications of new technologies in clinical testing
Print
This POSTnote describes clinical testing technologies and their status in the UK, and highlights some of the issues which may be of interest to Parliamentarians. POSTnote 4. POST. 1989. https://doi.org/10.58248/PN004
Publication type:
policy brief
Publication Date:
1989-07
Language:
en
Publication URL:
https://doi.org/10.58248/PN004
Institute(s):
Parliamentary Office of Science and Technology of the UK Parliament (POST)
Country:
United Kingdom of Great Britain & Northern Ireland